PBS vs Private Medications in the Doctor's Bag - The Complete Legal Framework

This article is intended for AHPRA-registered healthcare professionals in Australia. It provides general informational guidance on the legislative frameworks governing scheduled medicines in clinical practice and does not constitute legal advice. Requirements vary by state and territory.

Australian doctors routinely carry two fundamentally different categories of medication in their bag: PBS-funded items obtained free of charge through the Prescriber Bag scheme, and privately purchased items sourced through their own pharmacy or wholesaler. Many practitioners treat these as variations of the same thing. They are not. They are governed by entirely separate legal frameworks, with different procurement pathways, different cost arrangements, different supply rules, and different compliance obligations.

Understanding this distinction is not a technical nicety. Getting it wrong (conflating the two categories, using the wrong ordering mechanism, or assuming PBS rules apply to privately sourced stock) is one of the most common and consequential compliance failures regulators encounter in general practice audits.

This article sets out the complete legal framework.

The Three-Category Framework

To eliminate ambiguity, practitioners must conceptually separate three distinct categories of medication that may be present in a clinical setting at any time. Each has different legal characteristics, different procurement rules, and different obligations when supplied to patients.^[1]

Category 1: PBS Prescriber Bag (Doctor's Bag) Items

The PBS Prescriber Bag scheme is a Commonwealth funding mechanism under the National Health Act 1953 (Cth) and the National Health (Prescriber Bag Supplies) Determination 2024. It allows approved pharmacists to supply specific pharmaceutical benefit items, free of charge, to eligible prescribers for emergency use with patients.^[2]

Key legal characteristics of PBS prescriber bag items:

• Funded by the Commonwealth Government through the PBS
• Limited to the specific items listed in Schedule 1 of the National Health (Prescriber Bag Supplies) Determination 2024. The number of listed items and forms has varied over time as the schedule is amended; always confirm current items on the PBS website.
• Ordered using the PB052 Prescriber Bag Supply Order Book issued by Services Australia through HPOS
• Maximum quantities apply per calendar month per prescriber type, and where items share a Group Number in the Determination, the maximum quantity applies across all items in that group (not per individual item)^[2]
• Available only to eligible prescribers: AHPRA-registered medical practitioners, authorised nurse practitioners with PBS prescribing rights, and endorsed midwives with a scheduled medicines endorsement and PBS prescriber number. Each prescriber type has access to the items marked with their prescriber code (MP, NP, or MW respectively) in the Determination^[2]
• Must be supplied to patients free of charge. Because the prescriber received them at no cost, they cannot charge patients for these items.
• Ordering is limited to one order per calendar month^[2]

The governing law is federal. The authority to obtain these items comes from Commonwealth PBS legislation (specifically sections 93 and 93AB of the National Health Act 1953 (Cth)). The ordering form is Commonwealth stationery. The reimbursement is a Commonwealth payment to the pharmacist. Services Australia conducts audits of this scheme. It is a closed-loop, highly regulated federal subsidy.

Category 2: Private (Non-PBS) Practice Stock

Private practice stock refers to any scheduled medicine (Schedule 2, 3, 4, or 8) obtained by a medical practitioner through commercial means (pharmacy or licensed wholesaler) for in-practice clinical use, outside the PBS prescriber bag scheme.^[3]

Key legal characteristics of private practice stock:

• The practice bears the full cost of procurement. There is no government subsidy.
• Not limited to the PBS prescriber bag formulary. Any scheduled medicine the practitioner needs for legitimate clinical use may be obtained, subject to state and territory rules on possession and procurement.
• Governed entirely by state and territory drugs and poisons legislation, not Commonwealth PBS law
• Procured via a written requisition (or, in Queensland, a compliant purchase order) to a licensed pharmacist or directly from a licensed wholesaler
• Subject to state-specific storage, record-keeping, and disposal obligations
• May be charged to patients when administered. The prescriber paid for it and may recover the cost as part of the consultation.

The governing law is state and territory. The authority to possess and use these medicines derives from state-based drugs and poisons legislation, not federal PBS law. Each jurisdiction has its own Acts, Regulations, and enforcement bodies.

Category 3: Patient-Specific Prescriptions

Patient-specific supply is when a medicine is dispensed by a pharmacist pursuant to a prescription issued for a specific named patient. It is not "stock" at all. Legally, medication dispensed on a patient-specific prescription is the private property of that patient, not the clinic and not the prescriber.^[4]

This category exists here because a critical and surprisingly common compliance failure involves practitioners treating dispensed patient medications as available for other patients. NSW Health explicitly warns that urgent-use supply to practitioners must not be dispensed in the prescriber's own name. Fabricating a patient record in the doctor's name to acquire clinic stock is a serious breach of drugs and poisons legislation.^[5] Using patient prescriptions to build general practice stock constitutes misappropriation of patient property and bypasses all statutory procurement controls.

Why This Distinction Matters: The Two Legal Systems

The most important practical takeaway from the three-category framework is this: the PBS tells you what you can get for free; state and territory law tells you what you are authorised to possess and use.

These are two separate legal systems operating in parallel:

The Authority to Hold Private Stock

A common misconception is that a doctor's authority to hold medications is derived from the PBS. It is not. The PBS prescriber bag scheme is a funding mechanism. The legal authority to possess and use scheduled medicines comes entirely from state and territory drugs and poisons legislation.^[6]

In each jurisdiction, registered medical practitioners are granted a broad authorisation to obtain, possess, and use scheduled medicines in the lawful practice of their profession. The relevant enabling provisions include:

• Victoria: Drugs, Poisons and Controlled Substances Act 1981 (Vic), section 13(1)(a)^[7]
• NSW: Poisons and Therapeutic Goods Act 1966 (NSW) and the Poisons and Therapeutic Goods Regulation 2008 (NSW)^[5]
• Queensland: Medicines and Poisons Act 2019 (Qld), section 55^[9]
• WA: Medicines and Poisons Act 2014 (WA) and the Medicines and Poisons Regulations 2016 (WA)^[8]
• SA: Controlled Substances Act 1984 (SA)^[15]
• TAS: Poisons Act 1971 (Tas) and Poisons Regulations 2018 (Tas)^[16]
• ACT: Medicines, Poisons and Therapeutic Goods Act 2008 (ACT)^[17]
• NT: Medicines, Poisons and Therapeutic Goods Act 2012 (NT)^[18]

This authority is broad but conditional. It applies only when the possession and use falls within lawful practice: that is, for the genuine medical treatment of patients under the practitioner's direct care, within the practitioner's professional scope, and in compliance with the applicable storage and record-keeping rules. It does not authorise speculative stockpiling, wholesale redistribution, self-administration of controlled drugs, or possession beyond a quantity that can be objectively justified by clinical need.^[6]

Note on SA, TAS, ACT and NT: the specific procurement mechanics and permit requirements for non-PBS clinic stock in these jurisdictions were not fully established in the source materials reviewed. Practitioners in these states and territories should verify current requirements directly with their state or territory health department before establishing private stock arrangements. Do not assume that the VIC or NSW workflows apply unchanged.

Procurement: Two Completely Different Pathways

Ordering PBS Prescriber Bag Items

PBS prescriber bag items are ordered using the PB052 Prescriber Bag Supply Order Book, which is Commonwealth stationery issued by Services Australia through HPOS. Each order form is pre-printed for a specific calendar month and may only be used in that month. Completing the form and presenting it to an approved pharmacist triggers the Commonwealth reimbursement mechanism. The pharmacist supplies the items and claims the cost from the PBS.^[2]

Only items listed in Schedule 1 of the National Health (Prescriber Bag Supplies) Determination 2024 can be obtained this way, and only the items marked with your prescriber code. Non-PBS items cannot be added to the PB052 form. Pharmacists have no authority to process them through the PBS claiming system, and doing so would constitute an improper PBS claim. For the full explanation, see: Can You Write Non-PBS Items on the PB052 Form?

Ordering Private Practice Stock

Private practice stock is obtained via a written requisition (or, in Queensland, a compliant purchase order) to a licensed community pharmacist or licensed pharmaceutical wholesaler. A requisition is a written order from a registered health professional to a supplier, made in the professional's capacity as an authorised practitioner, for medicines needed for clinical use. It is not written for a specific patient.^[10]

A valid written requisition must include, at minimum:^[11]

• A unique order identifier
• The date of the order
• The prescriber's full name and AHPRA registration number
• The prescriber's practice address
• The premises where the stock will be kept and used
• The specific medicine, pharmaceutical form, strength, and quantity
• The prescriber's original signature
• A statement of purpose: "for administration in practice to patients under my care"

Jurisdiction note: the minimum content requirements above reflect a national baseline derived primarily from Queensland's purchase order framework and NSW's written order guidance. Some fields (particularly unique order identifier and delivery address) are explicitly required in Queensland but may not be specified to the same level of detail in all other jurisdictions. The safest approach is to adopt the national minimum in all cases, as it meets or exceeds the requirements of the strictest jurisdiction.^[11]

The pharmacist supplies at commercial cost, retains the requisition as a compliance record, and for Schedule 8 items records the transaction in their controlled drug register.^[12]

For a full walkthrough of the requisition process, see: How Australian Doctors Obtain Non-PBS Medications for the Doctor's Bag

Supply to Patients: The Critical Cost Rule

One of the most practically important differences between the two categories concerns what happens when a medication is administered to a patient.

PBS prescriber bag items must be supplied to patients free of charge. The rationale is straightforward: the Commonwealth supplied these items to the prescriber at no cost for the purpose of emergency supply to patients. The prescriber cannot make a profit on a free government benefit. Charging a patient for a PBS prescriber bag item constitutes improper billing and may expose the prescriber to recovery action under the National Health Act 1953 (Cth).^[2]

Privately purchased stock may be charged to patients. The prescriber paid full commercial cost for these items and is entitled to recover that cost as part of the consultation charge. This is a normal private practice transaction and should be documented in the clinical record and any billing documentation.

In practical terms, a GP administering anti-emetics from private stock during a home visit may charge for it. A GP administering a schedule-8  obtained via the PB052 form during a palliative care emergency must not charge for it.

Storage: Rules Apply to Both Categories

Both PBS-sourced and privately sourced scheduled medicines are subject to the same state and territory storage requirements once they are in the practitioner's possession. The source of the medicine (PBS or private) does not affect storage obligations.

At the Schedule 4 level, medicines must be stored in a lockable facility, kept secured against unauthorised access, with access restricted to authorised persons.^[13]

At the Schedule 8 level (which includes schedule-8s from the PBS prescriber bag schedule, as well as any S8 items obtained via private requisition), the requirements are more stringent and vary by jurisdiction:

• Victoria: Locked storage constructed to resist forcible entry. The Drugs, Poisons and Controlled Substances Regulations 2017 (Vic) specify minimum construction standards including steel plate thickness, a 6-lever lock, continuous welding, and the safe must be secured to a wall or floor.^[13]
• NSW: A locked safe or secure receptacle firmly attached to the structure of the premises. Where refrigeration is required, a locked box inside a restricted-access refrigerator is required.^[12]
• Queensland: A locked cabinet meeting Queensland Health's departmental standard for S8 secure storage.^[9]
• WA: A locked receptacle or approved secure place. Administration of S8 medicines must be recorded in a Schedule 8 register.^[8]
• SA, TAS, ACT, NT: Locked, compliant receptacle required. Specific construction and security standards vary. Verify current requirements with the relevant state or territory health authority before relying on workflows from other jurisdictions.

Regardless of jurisdiction, S8 keys or combinations must be held only by the authorised medical practitioner. Sharing safe access with administrative or nursing staff who are not independently authorised constitutes a breach of custody and is a primary audit failure point across all states.^[6]

The Five Critical Compliance Principles

Whether dealing with PBS bag items or privately sourced stock, five foundational legal principles apply to all scheduled medicines in a clinical setting. A failure in any of these areas creates audit exposure regardless of which procurement pathway was used.^[6]

1. Custody and Control

The registered medical practitioner who holds the medicines carries ultimate legal responsibility for their secure storage, administration, and record-keeping, regardless of what other staff may have physical access to. Custody cannot be loosely transferred. If S8 drugs are ordered under Dr X's AHPRA registration, Dr X remains legally liable for those drugs even if others access the safe.

2. Lawful Practice Limitation

The authority to possess scheduled medicines is conditional on the possession being within the scope of the practitioner's lawful clinical practice. A GP cannot order highly specialised anaesthetic agents without a valid clinical justification for their primary care setting. Self-administration of controlled drugs from clinic stock is expressly prohibited. Regulators treat formulary anomalies as primary indicators of diversion.

3. Reasonable Quantity

Procurement must be limited to a quantity that is objectively justifiable by actual clinical throughput. Regulators assess this by auditing patient volume, historical usage, shelf life, and wastage rates. Speculative bulk purchasing (particularly of S8 medicines) triggers investigations. This applies equally to PBS prescriber bag items (where maximum quantities are set by the Determination) and private stock (where the reasonable quantity principle is enforced through audit). Note that no single uniform statutory "reasonable quantity" number applies across all jurisdictions for private stock. The practical compliance standard is to document a quantity rationale aligned to clinical need and diversion minimisation.^[6]

4. No Resale and No Redistribution

Clinic stock (whether PBS or private) is procured for administration to patients under the direct care of the practice. A medical practice is not a licensed pharmaceutical wholesaler. Selling or redistributing excess stock to other practitioners or entities constitutes illegal wholesale supply of scheduled poisons.

5. No Delegation of Authority

A medical practitioner cannot delegate their personal legal authority to possess or procure scheduled drugs to an unqualified person. Practice managers and nurses cannot independently sign S8 purchase orders using the doctor's credentials. Multi-doctor clinic arrangements that pool stock without the required facility permit (where applicable in the relevant jurisdiction) create a custody chain that may not be lawfully authorised from the moment another practitioner accesses the stock. Permit requirements for shared or imprest stock vary by jurisdiction and must be verified locally.

Common Compliance Failures

Regulatory audits and civil tribunal hearings consistently identify the same structural failures. The following are the most frequent non-compliant models, all of which conflate or misapply the frameworks above.^[6]

Using prescriptions to build stock. Writing a prescription in a patient's name (or the doctor's own name) to acquire medications for general clinical use is unlawful. It misappropriates patient property, falsifies clinical records, and bypasses statutory procurement transparency. Regulators treat it as a mechanism for diversion. The correct instrument is a written requisition (or purchase order in Queensland), not a prescription.

Pooling stock across multiple doctors without a facility permit (where required). In Victoria, a multi-doctor clinic maintaining shared imprest stock may need to hold a Health Services Permit. Permit requirements for multi-practitioner stock arrangements vary by jurisdiction. Operating a shared central safe without the relevant permit, where one is required, means every practitioner drawing from it may be accessing stock without lawful authority, even if they each hold individual AHPRA registrations. The position in SA, TAS, ACT, and NT should be verified locally before establishing shared stock arrangements.

Charging patients for PBS prescriber bag items. PBS bag items must be supplied to patients free of charge. A prescriber who charges patients for medicines obtained via the PB052 form is in breach of the PBS supply conditions under the National Health Act 1953 (Cth).

Nurses independently controlling stock. The legal authority to possess S8 medicines rests with the registered medical practitioner. A clinic model where a practice nurse manages the drug safe, signs for deliveries, and maintains the S8 register independently of the prescriber represents a failure of custody and control and creates conditions for undetected diversion.

Telehealth prescribing combined with clinic-dispatched stock. A telehealth practitioner cannot issue a prescription and have a business entity dispatch the physical drug directly to the patient from a clinic cupboard. Dispensing medication to a patient pursuant to a prescription can only be done by a registered pharmacist from a registered pharmacy premises. This model constitutes operating an unlicensed pharmacy.

Practical Summary: Which Framework Applies?

When a prescriber needs to make a decision about a medication in their bag, the first question is always: where did this item come from?

• If it came via the PB052 form from an approved pharmacist: it is a PBS prescriber bag item. Supply to patients must be free. Governed by Commonwealth PBS law. Audited by Services Australia.
• If it was purchased via a written requisition (or Queensland purchase order) or wholesaler account: it is private practice stock. Cost may be recovered from patients. Governed by state/territory drugs and poisons law. Audited by the state health department and AHPRA.
• If it was dispensed by a pharmacist on a patient-specific prescription: it is patient property. It cannot be retained as clinic stock under any circumstances.

For the specific question of whether non-PBS items can appear on a PB052 form, see can you write non-PBS medications on the PB052?

For the PBS items you can obtain via the PB052 form, DocPouch provides a streamlined online ordering experience through Priceline Pharmacy, with free nationwide delivery.

Order Your PBS Prescriber Bag Online with DocPouch →

References

1. Therapeutic Goods Administration. Poisons Standard (SUSMP) -- Legislative Instrument Status and Current Edition. https://www.tga.gov.au/products/regulations-all-products/legislation-and-legislative-instruments/poisons-standard-susmp. See also: TGA. Scheduling Basics -- National Classification System Overview. https://www.tga.gov.au/products/regulations-all-products/ingredients-and-scheduling-medicines-and-chemicals/scheduling-national-classification-system/scheduling-basics-medicines-and-chemicals-australia
2. Australian Government Department of Health and Aged Care. Prescriber Bag (Doctor's Bag) -- Supply Rules, Order Form Requirements, Quantity Limits. PBS.gov.au. https://www.pbs.gov.au/info/browse/doctors-bag. See also: National Health (Prescriber Bag Supplies) Determination 2024 (F2024L00414), made under sections 93 and 93AB of the National Health Act 1953 (Cth). https://www.legislation.gov.au/F2024L00414/latest/text. And: Department of Health and Aged Care. Prescriber Bag Supplies for Endorsed Midwives -- Frequently Asked Questions (March 2025), noting endorsed midwife access via MW prescriber code effective 1 February 2025.
3. Victorian Department of Health. Medical Practitioners and Lawful Treatment -- Private Practice Stock vs PBS Prescriber Bag. https://www.health.vic.gov.au/drugs-and-poisons/medical-practitioners-and-lawful-treatment
4. Services Australia. PBS and RPBS Official Stationery. https://www.servicesaustralia.gov.au/pbs-and-rpbs-official-stationery?context=20
5. NSW Health. Supply of Prescription Medicines -- Urgent-Use Supply on Written Order; Prohibition on Dispensing in Prescriber's Name. https://www.health.nsw.gov.au/pharmaceutical/Pages/legal-form-prescription.aspx. See also: NSW. Poisons and Therapeutic Goods Regulation 2008. https://legislation.nsw.gov.au/view/whole/html/inforce/current/sl-2008-0392
6. For the five compliance principles and non-compliant models, see: Non-PBS Medications: Legal and Operational Guide for Australian Medical Practitioners (Healthcare Regulatory Compliance, April 2026), sections 5 and 6. See also: State-by-State Legal and Operational Guide for Australian Doctors Holding and Using Non-PBS Clinic Stock Medicines (April 2026). These principles are also reflected in: Victorian Civil and Administrative Tribunal (VCAT) disciplinary decisions; NSW Health Care Complaints Commission (HCCC) determinations; and Medical Board of Australia. Good Medical Practice: A Code of Conduct for Doctors in Australia. https://www.medicalboard.gov.au/Codes-Guidelines-Policies/Code-of-conduct.aspx
7. Victorian Department of Health. Medical Practitioners and Lawful Treatment. https://www.health.vic.gov.au/drugs-and-poisons/medical-practitioners-and-lawful-treatment. See also: Drugs, Poisons and Controlled Substances Act 1981 (Vic) s 13(1)(a). Note: section 13(2) clarifies this does not authorise retail sale in an open shop unless licensed to do so. AustLII: https://classic.austlii.edu.au/au/legis/vic/consol_act/dpacsa1981422/s13.html
8. Western Australia Department of Health. Requirements of the Medicines and Poisons Legislation -- WA. https://www.health.wa.gov.au/~/media/Corp/Policy-Frameworks/Public-Health/Medicines-Handling-Policy/Supporting/Requirements-of-the-Medicines-and-Poisons-Legislation.pdf. See also: WA. Medicines and Poisons Regulations 2016. WA Legislation. Note: The WA sources reviewed do not provide an explicit "clinic stock purchase order" rule equivalent to Queensland's purchase order regime. A WA-specific procurement SOP should be validated directly against the WA Regulations and current WA Department of Health directions. And: WA Health. Administration and Record-Keeping Guideline for S4 Restricted and S8 Medicines. https://healthywa.wa.gov.au
9. Queensland. Medicines and Poisons Act 2019 (Qld). https://www.legislation.qld.gov.au/view/whole/html/inforce/current/act-2019-026. And: Medicines and Poisons (Medicines) Regulation 2021 (Qld). https://www.legislation.qld.gov.au/view/whole/html/inforce/current/sl-2021-0140. And: Queensland Health. Key Legislative Requirements -- Medical Practitioners. https://www.health.qld.gov.au/__data/assets/pdf_file/0014/1144310/fs-medical-practitioners.pdf. And: Queensland Health. Storage and Record-Keeping for Schedule 8 Medicines. https://www.health.qld.gov.au/__data/assets/pdf_file/0024/1159071/storage-record-keeping-s8-medicines.pdf
10. Pharmaceutical Benefits Scheme. PBS Explanatory Notes -- Supplying Medicines: What Pharmacists Need to Know. Section 1.3. https://www.pbs.gov.au/info/healthpro/explanatory-notes/section1/Section-1-3-Explanatory-Notes
11. Queensland Health. Purchase Order Template -- Medicines and Poisons Act 2019. https://www.health.qld.gov.au/__data/assets/pdf_file/0014/1110821/tpl-purchase-order.pdf. See also: Medicines and Poisons (Medicines) Regulation 2021 (Qld). https://www.legislation.qld.gov.au/view/whole/html/inforce/current/sl-2021-0140. And: State-by-State Legal and Operational Guide (April 2026) -- national minimum content baseline.
12. NSW Health (Pharmaceutical Services). Management of Schedule 8 Medicines -- Ordering, Receipting, Storage, Registers, Destruction. https://www.health.nsw.gov.au/pharmaceutical/Pages/schedule-8-medicines.aspx
13. Victoria. Drugs, Poisons and Controlled Substances Regulations 2017 (Authorised Version No. 020, incorporating amendments as at 25 November 2025) -- S4 storage (reg 73); S8 storage (reg 75); record-keeping requirements. https://content.legislation.vic.gov.au/sites/default/files/2025-11/17-29sra020-authorised.pdf. See also: Victorian Department of Health. Schedule 8 Permits and Notifications. https://www.health.vic.gov.au/drugs-and-poisons/schedule-8-permits-and-notifications
14. Australian Commission on Safety and Quality in Health Care. Real-Time Prescription Monitoring -- All Jurisdictions. https://www.safetyandquality.gov.au/our-work/e-health-safety/real-time-prescription-monitoring
15. South Australia. Controlled Substances Act 1984 (SA). SA Health, Drugs of Dependence Unit. SA Health -- Drugs of Dependence. Note: procurement mechanics for non-PBS clinic stock in SA require verification with SA Health directly. As of 1 January 2026, S8 authority applications must be submitted via ScriptCheckSA.
16. Tasmania. Poisons Act 1971 (Tas); Poisons Regulations 2018 (Tas). https://classic.austlii.edu.au/au/legis/tas/consol_reg/pr2018230/. Note: full procurement mechanics for non-PBS clinic stock in Tasmania require direct implementation from in-force regulations with Tasmanian legal review.
17. ACT. Medicines, Poisons and Therapeutic Goods Act 2008 (ACT). https://www.legislation.act.gov.au/a/2008-26. Note: procurement, storage, and register requirements for ACT clinic-held S4/S8 stock must be implemented directly from ACT subordinate legislation and ACT Health directions. Do not assume NSW workflows apply unchanged.
18. NT. Medicines, Poisons and Therapeutic Goods Act 2012 (NT). NT Health. NT Health -- S8 prescription requirements. Note: NT non-PBS clinic stock procurement pathways require direct implementation from the NT Act and current NT Chief Health Officer directions.

Further Resources

• PBS Prescriber Bag Schedule -- PBS.gov.au
• National Health (Prescriber Bag Supplies) Determination 2024 -- Federal Register of Legislation
• Medical Practitioners and Lawful Treatment -- Victorian Department of Health
• Management of Schedule 8 Medicines -- NSW Health
• Purchase Order Template -- Queensland Health
• Real-Time Prescription Monitoring (all jurisdictions) -- ACSQHC
• DocPouch: Can You Write Non-PBS Items on the PB052 Form?
• DocPouch: How Australian Doctors Obtain Non-PBS Medications for the Doctor's Bag
• DocPouch: Complete Guide to the PBS Doctor's Bag Scheme

Disclaimer: This article is intended for AHPRA-registered healthcare professionals in Australia and summarises publicly available information about the legislative frameworks governing scheduled medicines obtained under the PBS Prescriber Bag scheme and through private procurement. It does not constitute legal, medical, pharmaceutical, compliance, or regulatory advice, and is not intended as advertising of any therapeutic good under the Therapeutic Goods Act 1989 (Cth). No specific medicines, brands, strengths, or dosages are referenced. The supply of pharmaceutical benefits under the PBS Prescriber Bag scheme is governed by the National Health Act 1953 (Cth) and the National Health (Prescriber Bag Supplies) Determination 2024. The authority of practitioners to possess and use scheduled medicines obtained outside the scheme is governed by state and territory drugs and poisons legislation, which varies between jurisdictions and takes precedence over any general guidance. Practitioners are responsible for verifying current requirements with their jurisdiction's health authority and for complying with all applicable Commonwealth, state, and territory legislation. Independent legal advice should be obtained where required. PBS Prescriber Bag supplies may be obtained from any approved pharmacy under the scheme, including community pharmacies, hospital pharmacies, and pharmacy-operated online ordering services. Sources: see references listed above. DocPouch (www.docpouch.com.au) is an ordering platform and does not provide legal advice. Last reviewed: April 2026.